Empresa Advanced Oncotherapy PLC London S.E.
Acciones
GB00B16JQ761
Equipo médico y tecnología avanzada
Precio de cierre
Otros sitios de cotización
|
||
- GBX | - |
03/05 | Continúan las conversaciones de financiación de Advanced Oncotherapy, se retrasan los fondos | AN |
02/04 | Sareum aumenta su oferta minorista; SThree ficha a un antiguo ejecutivo de ITV | AN |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 49 | 27/08/14 | |
Director of Finance/CFO | - | 01/10/16 | |
Michael Sinclair
CHM | Chairman | 82 | 16/06/06 |
Jonathan Farr
CTO | Chief Tech/Sci/R&D Officer | - | 14/06/17 |
Ed Lee
COO | Chief Operating Officer | - | 01/02/17 |
David Navas
IRC | Investor Relations Contact | - | - |
Henry Clarke
SEC | Corporate Secretary | - | 19/05/19 |
Bridget Biggar
HRO | Human Resources Officer | - | 01/11/16 |
Graham Pughe
AUD | Comptroller/Controller/Auditor | - | 01/12/12 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Lori Jo Cross
BRD | Director/Board Member | 64 | 29/09/20 |
Michael Sinclair
CHM | Chairman | 82 | 16/06/06 |
Hans von Celsing
BRD | Director/Board Member | 74 | 26/01/17 |
Director/Board Member | 73 | 01/10/13 | |
Ren Hua Zhang
BRD | Director/Board Member | 58 | 28/08/18 |
Director/Board Member | 72 | 26/04/13 | |
Director/Board Member | 74 | 09/02/17 | |
Chief Executive Officer | 49 | 27/08/14 | |
Stephen Myers
BRD | Director/Board Member | 78 | 26/01/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 542 573 869 | 284 689 154 ( 52,47 %) | 0 | 52,47 % |
Información de la empresa
Advanced Oncotherapy Plc
4 Tenterden Street Third Floor
W1S 1TE, London
+44 20 3617 8728
http://advancedoncotherapy.comSector
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+7,84 % | 218 mil M | |
+7,35 % | 184 mil M | |
+13,04 % | 135 mil M | |
+26,03 % | 107 mil M | |
-1,33 % | 62,38 mil M | |
+11,80 % | 51,37 mil M | |
+4,81 % | 50,9 mil M | |
+0,30 % | 40,87 mil M | |
+2,78 % | 36,28 mil M |
- Bolsa de valores
- Acciones
- Acción AVO
- Acción
- Empresa Advanced Oncotherapy PLC